This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Affymax(AFFY) is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis. This stock is trading up 5% at $17.81 in recent trading.
Today's Volume: 1.2 million
Average Volume: 1
Volume % Change: 130%
>>5 Stocks Poised for Breakouts
From a technical perspective, AFFY is ripping higher here right off some near-term support at $17 with above average volume. This move has also pushed AFFY into breakout territory, since the stock has taken out some near-term overhead resistance levels at $17.16 to $17.33. This move has also pushed AFFY into new 52-week high territory, which is bullish technical price action.
Traders should continue to look for long-biased traders as long as AFFY is trending above today's low of $16.95 with strong upside volume flows. I would consider any upside volume day that registers near or above 1 million shares as bullish. If AFFY can hold that trend, then this stock has a great chance of hitting $20 in the near future.
I also featured AFFY earlier this month in "
5 Hated Stocks Set to Soar on Earnings."